NASDAQ:CERC - Cerecor Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$4.26 +0.13 (+3.15 %)
(As of 07/16/2018 10:43 AM ET)
Previous Close$4.26
Today's Range$4.26 - $4.26
52-Week Range$0.52 - $5.74
Volume1,000 shs
Average Volume60,884 shs
Market Capitalization$129.61 million
P/E Ratio9.83
Dividend YieldN/A
Beta1.34
Cerecor Inc., a pharmaceutical company, focuses on pediatric health care. Its lead product portfolio includes prescribed dietary supplements, such as Poly-Vi-Flor and Tri-Vi-Flor; and prescription drugs, such as Millipre, Veripred, and Ulesfia for the treatment of inflammation of the skin, joints, lungs, and other organs, as well as asthma, allergies, arthritis, and head lice infestation. It also offers Karbinal ER, AcipHex Sprinkle, and Cefaclor for oral suspension; and Flexichamber. The company is developing CERC-301, an orphan neurological indication for controlling neurologic adaptation; CERC-611, a drug candidate for the treatment of partial-onset seizures in epilepsy; and two preclinical stage development candidates, CERC-406 and CERC-425 potential for the treatment of motoric and non-motoric symptoms of Parkinson's disease, as well as other psychiatric and neurological conditions. The company was formerly known as Ceregen Corporation and changed its name to Cerecor Inc. in March 2011. Cerecor Inc. was founded in 2011 and is headquartered in Baltimore, Maryland.

Receive CERC News and Ratings via Email

Sign-up to receive the latest news and ratings for CERC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:CERC
CUSIPN/A
Phone410-522-8707

Debt

Debt-to-Equity Ratio0.59
Current Ratio0.91
Quick Ratio0.67

Price-To-Earnings

Trailing P/E Ratio9.83
Forward P/E Ratio-10.92
P/E GrowthN/A

Sales & Book Value

Annual Sales$27.81 million
Price / Sales4.81
Cash Flow$0.4919 per share
Price / Cash8.66
Book Value$1.07 per share
Price / Book3.98

Profitability

EPS (Most Recent Fiscal Year)$0.42
Net Income$11.86 million
Net Margins31.17%
Return on Equity59.50%
Return on Assets32.38%

Miscellaneous

Employees38
Outstanding Shares31,380,000
Market Cap$129.61

The Truth About Cryptocurrencies

Cerecor (NASDAQ:CERC) Frequently Asked Questions

What is Cerecor's stock symbol?

Cerecor trades on the NASDAQ under the ticker symbol "CERC."

How were Cerecor's earnings last quarter?

Cerecor Inc (NASDAQ:CERC) posted its quarterly earnings data on Friday, May, 11th. The company reported ($0.07) earnings per share (EPS) for the quarter. The business had revenue of $4.48 million for the quarter. Cerecor had a return on equity of 59.50% and a net margin of 31.17%. View Cerecor's Earnings History.

When is Cerecor's next earnings date?

Cerecor is scheduled to release their next quarterly earnings announcement on Monday, August, 13th 2018. View Earnings Estimates for Cerecor.

What is the consensus analysts' recommendation for Cerecor?

0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cerecor in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A."

Who are some of Cerecor's key competitors?

Who are Cerecor's key executives?

Cerecor's management team includes the folowing people:
  • Mr. Peter S. Greenleaf, CEO & Director (Age 48)
  • Ms. Mariam E. Morris, CFO & Sec. (Age 50)
  • Dr. Solomon H. Snyder M.D., Founder and Chairman of Scientific Advisory Board (Age 79)
  • Dr. Barbara S. Slusher Ph.D., Founder and Member of Scientific Advisory Board (Age 53)
  • Mr. James Archie Harrell Jr., Exec. VP of Marketing & External Communications

Has Cerecor been receiving favorable news coverage?

News stories about CERC stock have trended somewhat positive recently, Accern Sentiment Analysis reports. The research group identifies negative and positive media coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Cerecor earned a news impact score of 0.09 on Accern's scale. They also assigned news coverage about the company an impact score of 45.96 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.

How do I buy shares of Cerecor?

Shares of CERC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cerecor's stock price today?

One share of CERC stock can currently be purchased for approximately $4.26.

How big of a company is Cerecor?

Cerecor has a market capitalization of $129.61 million and generates $27.81 million in revenue each year. The company earns $11.86 million in net income (profit) each year or $0.42 on an earnings per share basis. Cerecor employs 38 workers across the globe.

How can I contact Cerecor?

Cerecor's mailing address is 400 E. Pratt Street Suite 606, Baltimore MD, 21202. The company can be reached via phone at 410-522-8707 or via email at [email protected]


MarketBeat Community Rating for Cerecor (NASDAQ CERC)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  77 (Vote Outperform)
Underperform Votes:  83 (Vote Underperform)
Total Votes:  160
MarketBeat's community ratings are surveys of what our community members think about Cerecor and other stocks. Vote "Outperform" if you believe CERC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CERC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/16/2018 by MarketBeat.com Staff

Featured Article: Earnings Per Share (EPS)

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.